Literature DB >> 30635146

Direct oral anticoagulants vs non-vitamin K antagonist in atrial fibrillation: A prospective, propensity score adjusted cohort study.

Marco Marietta1, Federico Banchelli2, Piercamillo Pavesi3, Cesare Manotti4, Roberto Quintavalla4, Tiziana Sinigaglia5, Giuliana Guazzaloca6, Corrado Pattacini7, Stefano Urbinati8, Vincenzo Livio Malavasi9, Giuseppe Boriani9, Claudio Voci10, Roberto D'Amico11, Nicola Magrini12.   

Abstract

Entities:  

Keywords:  Anti-vitamin k; Apixaban; Atrial fibrillation; Dabigatran; Direct oral anticoagulants; Propensity score; Rivaroxaban

Mesh：

Substances：

Year:  2019        PMID： 30635146     DOI： 10.1016/j.ejim.2018.12.010

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN： 0953-6205            Impact factor:   4.487


× No keyword cloud information.
  3 in total

1.  Atrial fibrillation pattern and factors affecting the progression to permanent atrial fibrillation.

Authors:  Vincenzo Livio Malavasi; Elisa Fantecchi; Virginia Tordoni; Laura Melara; Andrea Barbieri; Marco Vitolo; Gregory Y H Lip; Giuseppe Boriani
Journal:  Intern Emerg Med       Date:  2020-11-07       Impact factor: 3.397

2.  Estimated Thresholds of Minimum Necessary Adherence for Effective Treatment with Direct Oral Anticoagulants - A Retrospective Cohort Study in Health Insurance Claims Data.

Authors:  Lucas Wirbka; Walter Emil Haefeli; Andreas Daniel Meid
Journal:  Patient Prefer Adherence       Date:  2021-09-24       Impact factor: 2.711

3.  Can Machine Learning from Real-World Data Support Drug Treatment Decisions? A Prediction Modeling Case for Direct Oral Anticoagulants.

Authors:  Andreas D Meid; Lucas Wirbka; Andreas Groll; Walter E Haefeli
Journal:  Med Decis Making       Date:  2021-12-15       Impact factor: 2.749
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.